BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3957953)

  • 1. Comparison of the cardiac effects of beta-adrenoreceptor agonists in anaesthetised and conscious dogs.
    Einstein R; Goodman AH; Yeoh EB
    J Auton Pharmacol; 1986 Mar; 6(1):9-14. PubMed ID: 3957953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative inotropic and chronotropic activity of beta-adrenoceptor stimulants in anaesthetised, areflexic dogs.
    Engel B; Einstein R; Goodman AH
    Eur J Pharmacol; 1983 Jan; 86(3-4):461-6. PubMed ID: 6131828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inotropic selectivity of salbutamol and terbutaline in anaesthetised, areflexic dogs.
    Engel B; Einstein R; Goodman AH
    Eur J Pharmacol; 1985 Oct; 116(1-2):97-104. PubMed ID: 4054218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular actions of dopexamine in anaesthetized and conscious dogs.
    Einstein R; Abdul-Hussein N; Wong TW; Chang DH; Matthews R; Richardson DP
    Br J Pharmacol; 1994 Jan; 111(1):199-204. PubMed ID: 7912154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive assessment of chronotropic and inotropic response to preferential beta-1 and beta-2 adrenoceptor stimulation.
    Corea L; Bentivoglio M; Verdecchia P; Motolese M; Sorbini CA; Grassi V; Tantucci C
    Clin Pharmacol Ther; 1984 Jun; 35(6):776-81. PubMed ID: 6145533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The haemodynamic effects of intravenous prenalterol and ouabain in conscious dogs.
    Ek L; Björkman JA; Carlsson E; Johansson B
    Acta Med Scand Suppl; 1982; 659():39-52. PubMed ID: 6127899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct versus reflex activation of cardiac beta-adrenoceptors in the chronotropic and inotropic effects of isoprenaline and prenalterol in the conscious dog.
    Berdeaux A; Edouard A; Giudicelli JF
    J Pharmacol; 1986; 17(3):266-74. PubMed ID: 2879069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardio-selective beta adrenergic stimulation with prenalterol in the conscious dog.
    Manders WT; Vatner SF; Braunwald E
    J Pharmacol Exp Ther; 1980 Oct; 215(1):266-70. PubMed ID: 6109017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inotropic, chronotropic and dromotropic effects of prenalterol, a new cardiostimulant drug.
    Moore EN; Aberg G; Spear JF; Hodess AB; Herrmann I; Adler G
    Acta Med Scand Suppl; 1982; 659():53-70. PubMed ID: 6958179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of selective and nonselective beta-agonists on plasma potassium and norepinephrine.
    Vincent HH; Boomsma F; Man in't Veld AJ; Derkx FH; Wenting GJ; Schalekamp MA
    J Cardiovasc Pharmacol; 1984; 6(1):107-14. PubMed ID: 6199591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenalterol as an antidote to massive doses of metoprolol--a cardiovascular study in the dog.
    Andersson T; Heath A; Mattsson H
    Acta Med Scand Suppl; 1982; 659():71-88. PubMed ID: 6127900
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of heart rate on the effects of prenalterol on regional myocardial blood flow and function during coronary stenosis in dogs.
    Berdeaux A; Bonhenry C; Duhazé P; Giudicelli JF; Thuillez C
    Br J Pharmacol; 1984 Sep; 83(1):203-10. PubMed ID: 6148979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased sensitivity to isoprenaline following digoxin pretreatment in anaesthetised and conscious dogs.
    Mihailidou AS; Einstein R; Richardson DP; Gray P; Jones MP; Hunyor SN
    Cardiovasc Res; 1990 Mar; 24(3):222-6. PubMed ID: 2346956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemodynamic effects of prenalterol in patients with severe congestive heart failure--NYHA III-IV.
    Erbel R; Meyer J; Schweizer P; Lambertz H; Voelker W; Effert S
    Acta Med Scand Suppl; 1982; 659():169-80. PubMed ID: 6127887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Echocardiographic comparison between prenalterol and dobutamine.
    Wester HA; Oltmanns D
    Acta Med Scand Suppl; 1982; 659():181-90. PubMed ID: 6127888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodynamic effects of prenalterol in patients with coronary heart disease.
    Hutton I; Murray RG; Boyes RN; Rae AP; Hillis WS
    Br Heart J; 1980 Feb; 43(2):134-7. PubMed ID: 6102468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.
    McCaffrey PM; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1987 Nov; 24(5):571-80. PubMed ID: 2893634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selectivity of xamoterol, prenalterol and salbutamol as assessed by their effects in the presence and absence of ICI 118 551.
    McCaffrey PM; Riddell JG; Shanks RG
    Eur Heart J; 1990 Apr; 11 Suppl A():54-5. PubMed ID: 1971592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basic pharmacological properties of prenalterol.
    Mattsson H; Hedberg A; Carlsson E
    Acta Med Scand Suppl; 1982; 659():9-37. PubMed ID: 6127902
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanisms of supersensitivity to sympathomimetic amines in the chronically denervated heart of the conscious dog.
    Vatner DE; Lavallee M; Amano J; Finizola A; Homcy CJ; Vatner SF
    Circ Res; 1985 Jul; 57(1):55-64. PubMed ID: 2988820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.